These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6969656)

  • 1. [Open study of L-5-H.T.P. in melancholic depressed patients over 50 years of age (author's transl)].
    Lôo H; Zarifian E; Wirth JF; Deniker P
    Encephale; 1980; 6(3):241-6. PubMed ID: 6969656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [L-5-hydroxytryptophan-(L-5-HTP) therapy].
    Sano I
    Folia Psychiatr Neurol Jpn; 1972 Jan; 26(1):7-17. PubMed ID: 4538204
    [No Abstract]   [Full Text] [Related]  

  • 3. [Psychopharmacologic treatment with (L-5-HTP), L-5 hydroxytryptophan in endogenous depressions].
    Sano I
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(1):223-31. PubMed ID: 4541701
    [No Abstract]   [Full Text] [Related]  

  • 4. ["Precursor therapy" with active amines. I. Treatment of depression by L-5-HTP (L-5-hydroxytryptophan)].
    Sano I
    Seishin Shinkeigaku Zasshi; 1971 Oct; 73(10):809-15. PubMed ID: 5316872
    [No Abstract]   [Full Text] [Related]  

  • 5. [DL-phenylalanine as an antidepressant. Open study (author's transl)].
    Beckmann H; Ludolph E
    Arzneimittelforschung; 1978; 28(8):1283-4. PubMed ID: 380577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [L-5-hydroxytryptophan(L-5-HTP) therapy in endogenous depression. 1].
    Sano I
    Munch Med Wochenschr; 1972 Oct; 114(40):1713-6. PubMed ID: 4538892
    [No Abstract]   [Full Text] [Related]  

  • 7. [New therapeutic possibilities in depression: 5-hydroxytryptophan].
    López-Ibor Aliño JJ; Ayuso Gutiérrez JL; Montejo Iglesias ML
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1975; 3(3):151-62. PubMed ID: 1099879
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems in clinical testing of a psychotropic substance examplified by L-5-HTP-ester (author's transl)].
    Gastpar M; Pühringer W; Graw P; Wirz-Justice A; Lacoste V
    Arzneimittelforschung; 1978; 28(8):1282-3. PubMed ID: 380576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crash treatment for melancholia. Resistant to other recently developed methods.
    Robie TR
    J Med Soc N J; 1970 Aug; 67(8):488-93. PubMed ID: 5310707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thyroid function in depressed patients].
    De Mendonça Lima CA; Vandel S; Bonin B; Bertschy G; Bizouard P
    Encephale; 1996; 22(2):85-94. PubMed ID: 8706626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-tryptophan and 5-hydroxytryptophan in the treatment of depression. A review.
    d'Elia G; Hanson L; Raotma H
    Acta Psychiatr Scand; 1978 Mar; 57(3):239-52. PubMed ID: 347886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open trial of venlafaxine for the treatment of late-life atypical depression.
    Roose SP; Miyazaki M; Devanand D; Seidman S; Fitzsimmons L; Turret N; Sackeim H
    Int J Geriatr Psychiatry; 2004 Oct; 19(10):989-94. PubMed ID: 15449363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of endogenous depression with L-hydroxy-tryptophan (L-5-HTP)].
    Sano I
    Nihon Rinsho; 1973 Jan; 31(1):185-90. PubMed ID: 4540359
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic use of viloxazine (Vivalan ICI) in depressed hospital out-patients (author's transl)].
    Kabes J; Dostal T
    Cesk Psychiatr; 1976 Dec; 72(6):384-9. PubMed ID: 1000703
    [No Abstract]   [Full Text] [Related]  

  • 15. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety.
    Wålinder J; Prochazka J; Odén A; Sjödin I; Dahl ML; Ahlner J; Bengtsson F
    Hum Psychopharmacol; 2006 Apr; 21(3):151-8. PubMed ID: 16444795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical beta-blockers are not associated with an increased risk of treatment for depression.
    Kaiserman I; Kaiserman N; Elhayany A; Vinker S
    Ophthalmology; 2006 Jul; 113(7):1077-80. PubMed ID: 16815397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personality differences between depressed melancholic and non-melancholic inpatients.
    Rubino IA; Zanasi M; Robone C; Siracusano A
    Aust N Z J Psychiatry; 2009 Feb; 43(2):145-8. PubMed ID: 19153922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression?
    Baune BT; Hohoff C; Roehrs T; Deckert J; Arolt V; Domschke K
    Neurosci Lett; 2008 May; 436(2):111-5. PubMed ID: 18387740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of nomifensine in the treatment of depressive states (author's transl)].
    Zermatten A; Cumps J
    Acta Psychiatr Belg; 1981; 81(4):379-98. PubMed ID: 7036657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.